{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:14:23Z","timestamp":1783386863779,"version":"3.54.6"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100023181","name":"Agencja Bada\u0144 Medycznych","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023181","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.psychres.2025.116878","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T07:52:47Z","timestamp":1764834767000},"page":"116878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cross-sectional analysis of ongoing clinical trials involving lamotrigine for mental disorders: Insights from ClinicalTrials.gov and the EU clinical trials"],"prefix":"10.1016","volume":"356","author":[{"given":"Damian","family":"Swieczkowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4061-775X","authenticated-orcid":false,"given":"Aleksander","family":"Kwa\u015bny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6343-8454","authenticated-orcid":false,"given":"Wies\u0142aw Jerzy","family":"Cuba\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2025.116878_bib0001","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1111\/epi.17696","article-title":"Investigation of cardiac arrhythmia events in patients treated with lamotrigine: FDA adverse event reporing system analysis","volume":"64","author":"Aboukaoud","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.psychres.2025.116878_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1651898","article-title":"Advancing drug safety in psychiatry: insights from pharmacogenomics of hypersensitivity reactions","volume":"16","author":"Alhaj","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.psychres.2025.116878_bib0003","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3390\/ph18101590","article-title":"Efficacy of lamotrigine in the treatment of unipolar and bipolar depression: Meta-Analysis of acute and maintenance randomised controlled trials","volume":"18","author":"Arnone","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.psychres.2025.116878_bib0004","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1212\/WNL.0000000000200189","article-title":"Cardiac safety of lamotrigine: still awaiting a verdict","volume":"98","author":"Auerbach","year":"2022","journal-title":"Neurology."},{"key":"10.1016\/j.psychres.2025.116878_bib0005","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1192\/bjp.2025.10307","article-title":"Lamotrigine treatment of mental health problems during the perinatal period","volume":"227","author":"Austin","year":"2025","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116878_bib0006","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/pcn.13866","article-title":"Flunitrazepam increases the risk of lamotrigine-induced cutaneous adverse reactions: Combined analysis of medical big data and clinical research","volume":"79","author":"Bando","year":"2025","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2025.116878_bib0007","doi-asserted-by":"crossref","DOI":"10.1177\/20451253211045870","article-title":"Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review","volume":"11","author":"Besag","year":"2021","journal-title":"Ther. adv. psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116878_bib0008","series-title":"StatPearls [Internet]","article-title":"Lamotrigine","author":"Betchel","year":"2023"},{"key":"10.1016\/j.psychres.2025.116878_bib0009","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40345-023-00304-9","article-title":"Differential characteristics of bipolar I and II disorders: a retrospective, cross-sectional evaluation of clinical features, illness course, and response to treatment","volume":"11","author":"Brancati","year":"2023","journal-title":"Int. J. Bipolar. Disord."},{"key":"10.1016\/j.psychres.2025.116878_bib0010","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s40263-025-01231-2","article-title":"Effects of antiseizure medications on lipid profile and weight in patients with epilepsy: A systematic review with Meta-analysis","volume":"39","author":"Chocho\u0142","year":"2025","journal-title":"CNS Drugs"},{"issue":"11","key":"10.1016\/j.psychres.2025.116878_bib0011","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.42581","article-title":"Paternal valproate use and neurodevelopmental disorder and congenital malformation risk in offspring","volume":"8","author":"Colas","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.psychres.2025.116878_bib0012","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.3390\/ijerph19042186","article-title":"Mobile applications in mood disorders and mental health: systematic search in apple app store and google play store and review of the literature","volume":"19","author":"Eis","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.psychres.2025.116878_bib0013","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s11096-025-01919-x","article-title":"Comparative efficacy and safety of alternatives to sodium valproate in the management of bipolar affective disorder in people of child-bearing age: a narrative review by the European Society of Clinical Pharmacy\u2019s mental health specialist interest group","volume":"47","author":"Fitzgerald","year":"2025","journal-title":"Int. J. Clin. Pharm."},{"key":"10.1016\/j.psychres.2025.116878_bib0014","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jad.2025.04.125","article-title":"Lithium and lamotrigine for the treatment of bipolar II disorder \u2013 a systematic review and meta-analysis of randomized trials","volume":"383","author":"Fredskild","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116878_bib0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/epi4.12475","article-title":"FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE\/AES Task Force","volume":"6","author":"French","year":"2021","journal-title":"Epilepsia. Open"},{"key":"10.1016\/j.psychres.2025.116878_bib0016","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S2215-0366(15)00450-2","article-title":"Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 \u00d7 2 factorial randomised trial","volume":"3","author":"Geddes","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2025.116878_bib0017","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1177\/0269881119844199","article-title":"Lamotrigine augmentation in treatment-resistant unipolar depression: A comprehensive meta-analysis of efficacy and safety","volume":"33","author":"Goh","year":"2019","journal-title":"J. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.psychres.2025.116878_bib0018","article-title":"Lamotrigine in the maintenance treatment of bipolar disorder","volume":"9","author":"Hashimoto","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.psychres.2025.116878_bib0019","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2309359","article-title":"Risk of autism after prenatal topiramate, valproate, or lamotrigine exposure","volume":"390","author":"Hern\u00e1ndez-D\u00edaz","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psychres.2025.116878_bib0020","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213643","article-title":"Risk of ventricular arrhythmia and sudden cardiac arrest among older patients using lamotrigine for epilepsy","volume":"105","author":"Ho","year":"2025","journal-title":"Neurology."},{"key":"10.1016\/j.psychres.2025.116878_bib0021","doi-asserted-by":"crossref","first-page":"19542","DOI":"10.1038\/s41598-025-01321-7","article-title":"Association of ventricular arrhythmias with lamotrigine: an observational cohort study","volume":"15","author":"Kim","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psychres.2025.116878_bib0023","doi-asserted-by":"crossref","first-page":"110599","DOI":"10.1016\/j.yebeh.2025.110599","article-title":"Comparative analysis of postpartum depression incidence in patients with epilepsy on levetiracetam or lamotrigine monotherapy during pregnancy","volume":"171","author":"Li","year":"2025","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.psychres.2025.116878_bib0024","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1017\/S1461145708009504","article-title":"Lamotrigine-associated rash: to rechallenge or not to rechallenge?","volume":"12","author":"Lorberg","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2025.116878_bib0025","doi-asserted-by":"crossref","first-page":"120064","DOI":"10.1016\/j.jad.2025.120064","article-title":"Updated insights on memory disorder associated risk of medication: A real-world pharmacovigilance analysis","volume":"390","author":"Mao","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116878_bib0026","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1097\/MJT.0000000000000535","article-title":"Lamotrigine uses in psychiatric practice","volume":"26","author":"Naguy","year":"2019","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.psychres.2025.116878_bib0027","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jad.2021.12.134","article-title":"Augmentation strategies for treatment resistant major depression: a systematic review and network meta-analysis","volume":"302","author":"Nu\u00f1ez","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116878_bib0028","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/YCO.0000000000000906","article-title":"Practical application of digital therapeutics in people with mood disorders","volume":"37","author":"Orsolini","year":"2024","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116878_bib0029","doi-asserted-by":"crossref","first-page":"118","DOI":"10.64719\/pb.4375","article-title":"Efficacy and tolerability of lamotrigine in borderline personality disorder: A systematic review and meta-analysis","volume":"50","author":"Pahwa","year":"2020","journal-title":"Psychopharmacol. Bull"},{"key":"10.1016\/j.psychres.2025.116878_bib0030","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/JCP.0000000000001424","article-title":"A single-blind randomized comparison of lithium and lamotrigine as maintenance treatments for managing bipolar II disorder","volume":"41","author":"Parker","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116878_bib0031","article-title":"Lamotrigine is not associated with differential clinical outcomes in a real-world sample of patients with unipolar depression receiving ketamine or esketamine","author":"Santucci","year":"2025","journal-title":"Psychopharmacol. (Berl)"},{"key":"10.1016\/j.psychres.2025.116878_bib0032","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jad.2008.02.004","article-title":"A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression","volume":"111","author":"Suppes","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116878_bib0033","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/ijnp\/pyaa033","article-title":"Pharmacological augmentation in unipolar depression: a guide to the guidelines","volume":"23","author":"Taylor","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2025.116878_bib0034","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.schres.2009.01.002","article-title":"The efficacy of lamotrigine in clozapine-resistant schizophrenia: a systematic review and meta-analysis","volume":"109","author":"Tiihonen","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2025.116878_bib0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40345-022-00268-2","article-title":"Differences between bipolar disorder types 1 and 2 support the DSM two-syndrome concept","volume":"10","author":"Tondo","year":"2022","journal-title":"Int. J. Bipolar Disord."},{"key":"10.1016\/j.psychres.2025.116878_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2025.01.019","article-title":"Is lamotrigine a teratogen?","volume":"126","author":"Vajda","year":"2025","journal-title":"Seizure"},{"issue":"8","key":"10.1016\/j.psychres.2025.116878_bib0037","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/0706743719855040","article-title":"Bipolar II Disorder: Frequent, Valid, and Reliable","volume":"64","author":"Vieta","year":"2019","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116878_bib0038","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.seizure.2014.12.001","article-title":"Risk of a lamotrigine-related skin rash: current meta-analysis and postmarketing cohort analysis","volume":"25","author":"Wang","year":"2015","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.psychres.2025.116878_bib0039","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3390\/cells11040645","article-title":"Ketamine and lamotrigine combination in psychopharmacology: Systematic review","volume":"11","author":"Wilkowska","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.psychres.2025.116878_bib0040","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1002\/oby.24362","article-title":"Long-term medication-induced weight change across common antiseizure medications: a target trial emulation study","volume":"33","author":"Yu","year":"2025","journal-title":"Obes. (Silver Spring)"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125005232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125005232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:34:50Z","timestamp":1783384490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178125005232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":39,"alternative-id":["S0165178125005232"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116878","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-sectional analysis of ongoing clinical trials involving lamotrigine for mental disorders: Insights from ClinicalTrials.gov and the EU clinical trials","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116878","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116878"}}